Slaterx

Name

Slaterx

Legal name

SlateRx, LLC

Website

https://slate-rx.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmacy Benefit Management

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Hospital & Medical Service Plans (6324)

akta.pro primary industry

PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)

akta.pro secondary industries

Manufacturer Contracting, Rebates & Revenue Management (HLAEAKAD), Formulary Management & Clinical Pharmacy Programs (HLAEAKAA), Claims Processing, Adjudication & Payment Integrity (HLAEAKAC)

Keywords

• Pharmacy benefit management
• PBM services
• Pharmacy benefits administration
• Drug cost management
• Pharmacy benefit consulting

Headquarters

HQ city

Boca Raton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmacy Benefit Management (PBM) Administration: SlateRx generates revenue through a single, fixed per member per month (PMPM) fee for clinical management services. This fee covers coverage determinations, appeals, peer-to-peer reviews, and all clinical management under one flat rate with no up-charges or hidden costs. The company also earns revenue through pass-through manufacturer compensation (rebates, admin fees, price protection payments) which is fully passed through to plan sponsors rather than retained.
2. 100% Pass-Through of Manufacturer Compensation: All money from pharmaceutical manufacturers including traditional rebates, manufacturing administration fees, price protection payments, data fees, and service fees is passed through directly to plan sponsors. SlateRx does not retain any portion of manufacturer compensation.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

SlateRx provides pharmacy benefit management (PBM) services through its proprietary PBX (Pharmacy Benefit Experience) model, combining the financial scale and infrastructure of a large PBM with the concierge service of a pharmacy benefit administrator (PBA). The company offers 100% pass-through of manufacturer rebates, custom clinical management with an independent P&T committee, fiduciary contract protections, and access to 3.75 million covered lives through a sole-source coalition. All services are delivered under a single flat per-member-per-month (PMPM) fee to plan sponsors including employers, labor unions, public sector organizations, and health systems.

Product overview

SlateRx operates as a PBX™ (Pharmacy Benefit Experience), combining PBM and PBA functionality into a single unified offering. The core PBX™ product delivers the financial scale and infrastructure of a large PBM paired with the concierge service of a PBA. Supporting modules include Custom Clinical Model with independent P&T committee oversight, Fiduciary Protection Services, Prior Authorization Services, GLP-1 and Biosimilar Management Programs, Specialty Drug Management, Formulary Management, and Buying Power Aggregation providing access to 3.75 million covered lives. All services are delivered through a transparent, pass-through pricing model with a single flat PMPM fee.

Differentiator

Problem solved

Functional benefit

Products and services

• PBX (Pharmacy Benefit Experience) SlateRx's flagship pharmacy benefit model that combines the financial value of a large PBM with the concierge service and transparency of a PBA, delivering control, flexibility, and substantial savings to plan sponsors (employers, coalitions, labor unions, public sector organizations, and health systems).
• Custom Clinical Model Independent Pharmacy and Therapeutics (P&T) committee oversight and utilization management services including formulary development, coverage determinations, appeals, and prescriber engagement programs, ensuring clinical decisions are independent from PBM financial interests.
• Fiduciary Protection Services Contractual fiduciary obligations including duties to plan, duties to members and pharmacies, disclosure of conflicts of interest, and good faith obligations, embedded in customer contracts.
• Buying Power Aggregation Access to 3.75 million covered lives through the largest sole-source coalition of plan sponsors, providing negotiation strength and material contract protections including MAC list, audit rights, and performance guarantees.
• GLP-1 Management Program Clinical program for managing GLP-1 medications including coverage decisions, utilization controls, and indication-specific clinical criteria for diabetes and weight management indications, with chart notes requirements, supply limits, and plan control options.
• Biosimilar Management Program Strategic approach to biosimilar adoption that prioritizes lower-cost biosimilar alternatives over reference biologics on formulary, enabling cost savings without sacrificing clinical quality.
• Specialty Drug Management Control mechanisms for high-cost specialty medications including fulfillment through lowest-cost channels, individualized solutions for complex conditions, and specialty utilization management.
• Formulary Management High-efficiency formulary development and management with customizable options, including 2026 Premium Formulary, Flex UM, and Select Formulary variants.
• Prior Authorization Services Coverage determination and prior authorization processing including clinical criteria review, appeals handling, and peer-to-peer reviews for medications requiring authorization.

Quantifiable outcome

• 15% savings on day one based on pure unit costs
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

One partnership is on record.

• HealthTrustcoreStrategic or Co-development Partner · 8 January 2024SlateRx operates in partnership with HealthTrust, a leading healthcare performance improvement company. This collaboration brings together a unique pharmacy benefit solution combining HealthTrust's scale and infrastructure with SlateRx's PBX model. Joey Dizenhouse joined SlateRx as President & CEO from his role at HealthTrust where he managed over $15 billion in annual pharmacy spend. The partnership enables SlateRx to leverage HealthTrust's channel partners and deliver value to HealthTrust members.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Capital Rx: Capital Rx is a venture-backed, technology-led PBM operating the Judi platform with a transparent, pass-through pricing model and independent P&T oversight. It is the closest direct competitor to SlateRx, targeting self-insured employers and competing on transparency, fiduciary alignment, and modern technology architecture.
• SmithRx: SmithRx is a transparent PBM focused on self-insured employers with a flat-fee pass-through pricing model and modern technology platform. It competes head-to-head with SlateRx in the same employer and broker channel, with similar messaging around fiduciary alignment and rebate transparency.
• EmpiRx Health: EmpiRx Health is a pharmacy benefit manager that markets a transparent, pass-through model targeted at self-insured employers, health systems, and labor unions. It is a close peer in customer segment (employers, unions) and value proposition (transparent pricing, clinical management).
• Navitus Health Solutions: Navitus is a pass-through PBM owned by Costco and other health systems, serving health plans, employers, labor unions, and government programs. It competes with SlateRx on transparent pricing, no-spread model, and clinical program customization for similar plan sponsor types.
• MedImpact Healthcare Systems: MedImpact is an independent, pass-through PBM serving health plans, employers, and government programs. It competes with SlateRx on transparent pricing models and clinical management customization, particularly for mid-to-large employer and public-sector plans.
• Prime Therapeutics: Prime Therapeutics is a PBM owned by a coalition of Blue Cross Blue Shield health plans, focused on serving health plan clients with a transparent, aligned model. It is a peer in the health plan and coalition channel and shares the mission of bringing plan-sponsor-aligned economics to PBM services.

Emerging players

• RxBenefits: RxBenefits is a pharmacy benefits optimizer that partners with benefits brokers to deliver PBM solutions to mid-market and smaller employers. It shares SlateRx's broker/advisor-led GTM motion and target customer (employers, coalitions) but works as an intermediary layer over underlying PBMs rather than as a PBM itself.

Broad incumbents

• OptumRx: OptumRx is the largest U.S. PBM and part of UnitedHealth Group, serving employers, health plans, and government programs at massive scale. It represents the dominant incumbent against which SlateRx positions itself on transparency and fiduciary alignment, and is increasingly introducing its own pass-through product variants.
• Express Scripts: Express Scripts is one of the three largest U.S. PBMs, serving employers, health plans, and government programs. As an incumbent, it competes with SlateRx across the full plan sponsor spectrum and has been launching transparent pricing options in response to PBM reform pressure.
• CVS Caremark: CVS Caremark is the PBM arm of CVS Health and one of the three largest U.S. PBMs. It competes with SlateRx for employer, union, and health system pharmacy benefit contracts, and is responding to regulatory and reputational pressure with its own transparency and pass-through offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/slaterx

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Slaterx